Retraction notice to Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity [Surgery -September 2004, Pages 548-556] (Surgery (2004) 136(3) (548–556), (S0039606004002740), (10.1016/j.surg.2004.05.032));Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity

Surgery

Volumn 136, Issue 3, 2004, Pages 548-556

  Ito, Hiromichi ^a   Duxbury, Mark ^a   Zinner, Michael J ^a   Ashley, Stanley W ^a   Whang, Edward E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GLUCOSE TRANSPORTER 1; MATRIGEL; RNA;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS POTENTIAL; NUDE MOUSE; PANCREAS CARCINOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; XENOGRAFT; ZYMOGRAPHY;

EID: 4444302818     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2023.01.009     Document Type: Erratum

References (28)

1. K.J. Isselbacher Sugar and amino acid transport by cells in culture-differences between normal and malignant cells N Engl J Med 286 1972 929 933
2. R.S. Haber, A. Rathan, K.R. Weiser, A. Pritsker, S.H. Itzkowitz, and C. Bodian GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis Cancer 83 1998 34 40
3. T. Ito, Y. Noguchi, S. Satoh, H. Hayashi, Y. Inayama, and H. Kitamura Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage Mod Pathol 11 1998 437 443
4. R.S. Haber, K.R. Weiser, A. Pritsker, I. Reder, and D.E. Burstein GLUT1 glucose transporter expression in benign and malignant thyroid nodules Thyroid 7 1997 363 367
5. T. Kalir, B.Y. Wang, M. Goldfischer, R.S. Haber, I. Reder, and R. Demopoulos Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia Cancer 94 2002 1078 1082
6. M. Younes, R.W. Brown, D.R. Mody, L. Fernandez, and R. Laucirica GLUT1 expression in human breast carcinoma: correlation with known prognostic markers Anticancer Res 15 1995 2895 2898
7. J.D. Chandler, E.D. Williams, J.L. Slavin, J.D. Best, and S. Rogers Expression and localization of GLUT1 and GLUT12 in prostate carcinoma Cancer 97 2003 2035 2042
8. T. Kawamura, T. Kusakabe, T. Sugino, K. Watanabe, T. Fukuda, and A. Nashimoto Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival Cancer 92 2001 634 641
9. S.N. Reske, K.G. Grillenberger, G. Glatting, M. Port, M. Hildebrandt, and F. Gansauge Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma J Nucl Med 38 1997 1344 1348
10. J. Gardner-Thorpe, H. Ito, S.W. Ashley, and E.E. Whang Differential display of expressed genes in pancreatic cancer cells Biochem Biophys Res Commun 293 2002 391 395
11. J.Y. Yu, S.L. DeRuiter, and D.L. Turner RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells Proc Natl Acad Sci U S A 99 2002 6047 6052
12. G.S. Herron, Z. Werb, K. Dwyer, and M.J. Banda Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity J Biol Chem 261 1986 2810 2813
13. S. Ito, T. Fukusato, T. Nemoto, H. Sekihara, Y. Seyama, and S. Kubota Coexpression of glucose transporter 1 and matrix metalloproteinase-2 in human cancers J Natl Cancer Inst 94 2002 1080 1091
14. J. Bian, and Y. Sun Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter Mol Cell Biol 17 1997 6330 6338
15. S. Kubota, H. Ito, Y. Ishibashi, and Y. Seyama Anti-alpha3 integrin antibody induces the activated form of matrix metalloprotease-2 (MMP-2) with concomitant stimulation of invasion through Matrigel by human rhabdomyosarcoma cells Int J Cancer 70 1977 106 111
16. X. Yang, E.D. Staren, J.M. Howard, T. Iwamura, J.E. Bartsch, and H.E. Appert Invasiveness and MMP expression in pancreatic carcinoma J Surg Res 98 2001 33 39
17. M. Younes, L.V. Lechago, J.R. Somoano, M. Mosharaf, and J. Lechago Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers Cancer Res 56 1996 1164 1167
18. T. Yamamoto, Y. Seino, H. Fukumoto, G. Koh, H. Yano, and N. Inagaki Over-expression of facilitative glucose transporter genes in human cancer Biochem Biophys Res Commun 170 1990 223 230
19. A. Behrooz, and F. Ismail-Beigi Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation J Biol Chem 272 1997 5555 5562
20. J.S. Flier, M.M. Mueckler, P. Usher, and H.F. Lodish Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes Science 235 1987 1492 1495
21. R.C. Osthus, H. Shim, S. Kim, Q. Li, R. Reddy, and M. Mukherjee Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc J Biol Chem 275 2000 21797 21800
22. P.S. Moore, B. Sipos, S. Orlandini, C. Sorio, F.X. Real, and N.R. Lemoine Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4 Virchows Arch 439 2001 798 802
23. Z. Lin, J.M. Weinberg, R. Malhotra, S.E. Merritt, L.B. Holzman, and F.C. Brosius 3rd. GLUT-1 reduces hypoxia-induced apoptosis and JNK pathway activation Am J Physiol Endocrinol Metab 278 2000 E958 E966
24. Srinivasan S, Bernal-Mizrachi E, Ohsugi M, Permutt MA. Glucose promotes pancreatic islet beta-cell survival through a PI 3-kinase/Akt-signaling pathway. Am J Physiol Endocrinol Metab283.
25. C.R. Hauck, D.A. Hsia, X.S. Puente, D.A. Cheresh, and D.D. Schlaepfer FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth Embo J 21 2002 6289 6302
26. J. Liao, J.C. Wolfman, and A. Wolfman K-ras regulates the steady-state expression of matrix metalloproteinase 2 in fibroblasts J Biol Chem 278 2003 31871 31878
27. M.S. Duxbury, H. Ito, M.J. Zinner, S.W. Ashley, and E.E. Whang RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine Oncogene 23 2003 1539 1548
28. N.R. Wall, and Small Shi Y. RNA: Can RNA interference be exploited for therapy? Lancet 362 2003 1401 1403